Literature DB >> 23490072

Serum testosterone levels are related to cognitive function in men with schizophrenia.

L Moore1, M Kyaw, A Vercammen, R Lenroot, J Kulkarni, J Curtis, M O'Donnell, V J Carr, C Shannon Weickert, T W Weickert.   

Abstract

BACKGROUND: Sex steroids such as oestrogen and testosterone are potent neurodevelopmental hormones that also play a role in neuromodulation and neuroprotection of the mature brain. Sex steroid hormones may also be involved in the pathophysiology of schizophrenia as reduced circulating sex steroid levels and changes in brain sex steroid receptors are found in people with schizophrenia compared to controls. In men with schizophrenia, recent studies have documented an inverse correlation between serum testosterone and negative symptoms. Our study sought to confirm whether men with schizophrenia had lower levels of testosterone relative to controls and to determine whether lower testosterone levels were related to higher symptom severity and impaired cognition.
METHOD: Circulating serum hormone levels (testosterone, oestrogen, and prolactin), cognitive function and symptoms were assessed in 29 chronically ill men with schizophrenia or schizoaffective disorder. Twenty healthy men were recruited as a comparison group. A series of regression analyses were performed to determine the extent to which circulating sex steroid hormone levels predict cognition and symptoms in men with schizophrenia.
RESULTS: We did not find a significant difference in serum testosterone levels between groups. However, circulating testosterone levels significantly predicted performance on verbal memory, processing speed, and working memory in men with schizophrenia. With the exception of an effect of oestrogen on verbal memory, circulating sex steroid levels did not predict cognitive function in healthy men. Testosterone levels were not related to positive or negative symptom severity, but testosterone influenced excitement/hostility levels in our schizophrenia sample.
CONCLUSIONS: The results suggest that circulating sex steroids may modulate cognitive deficits associated with schizophrenia.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Memory; Negative symptoms; Processing speed; Schizophrenia; Testosterone; Working memory

Mesh:

Substances:

Year:  2013        PMID: 23490072     DOI: 10.1016/j.psyneuen.2013.02.007

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  19 in total

Review 1.  Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.

Authors:  Meritxell Tost; José Antonio Monreal; Antonio Armario; Juan David Barbero; Jesús Cobo; Clemente García-Rizo; Miquel Bioque; Judith Usall; Elena Huerta-Ramos; Virginia Soria; Javier Labad
Journal:  Clin Drug Investig       Date:  2020-01       Impact factor: 2.859

2.  Association of serum VEGF levels with prefrontal cortex volume in schizophrenia.

Authors:  A Pillai; K R Howell; A O Ahmed; D Weinberg; K M Allen; J Bruggemann; R Lenroot; D Liu; C Galletly; C S Weickert; T W Weickert
Journal:  Mol Psychiatry       Date:  2015-07-14       Impact factor: 15.992

3.  Local N-methyl-d-aspartate receptor antagonism in the prefrontal cortex attenuates spatial cognitive deficits induced by gonadectomy in adult male rats.

Authors:  M N Locklear; S Bhamidipaty; M F Kritzer
Journal:  Neuroscience       Date:  2014-12-27       Impact factor: 3.590

4.  Sex-Specific Associations of Androgen Receptor CAG Trinucleotide Repeat Length and of Raloxifene Treatment with Testosterone Levels and Perceived Stress in Schizophrenia.

Authors:  Samantha J Owens; Thomas W Weickert; Tertia D Purves-Tyson; Ellen Ji; Christopher White; Cherrie Galletly; Dennis Liu; Maryanne O'Donnell; Cynthia Shannon Weickert
Journal:  Mol Neuropsychiatry       Date:  2018-11-20

Review 5.  The effects of early life stress on motivated behaviors: A role for gonadal hormones.

Authors:  Samantha R Eck; Debra A Bangasser
Journal:  Neurosci Biobehav Rev       Date:  2020-10-03       Impact factor: 8.989

6.  Hormone levels are related to functional compensation in prolactinomas: A resting-state fMRI study.

Authors:  Shun Yao; Pan Lin; Matthew Vera; Farhana Akter; Ru-Yuan Zhang; Ailiang Zeng; Alexandra J Golby; Guozheng Xu; Yanmei Tie; Jian Song
Journal:  J Neurol Sci       Date:  2020-02-01       Impact factor: 3.181

7.  Selective enhancement of NMDA receptor-mediated locomotor hyperactivity by male sex hormones in mice.

Authors:  Maarten van den Buuse; Jac Kee Low; Perrin Kwek; Sally Martin; Andrea Gogos
Journal:  Psychopharmacology (Berl)       Date:  2017-07-03       Impact factor: 4.530

8.  Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in Schizophrenia.

Authors:  Jochen Kindler; Cynthia Shannon Weickert; Ashley J Skilleter; Stanley V Catts; Rhoshel Lenroot; Thomas W Weickert
Journal:  Neuropsychopharmacology       Date:  2015-04-01       Impact factor: 7.853

9.  Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia.

Authors:  T W Weickert; D Weinberg; R Lenroot; S V Catts; R Wells; A Vercammen; M O'Donnell; C Galletly; D Liu; R Balzan; B Short; D Pellen; J Curtis; V J Carr; J Kulkarni; P R Schofield; C S Weickert
Journal:  Mol Psychiatry       Date:  2015-05-18       Impact factor: 15.992

10.  Relationship of Brain-Derived Neurotrophic Factor with Interleukin-23, Testosterone and Disease Severity in Schizophrenia.

Authors:  Priya Allimuthu; Hanumanthappa Nandeesha; Raghavi Chinniyappan; Balaji Bhardwaz; Jesudas Blessed Raj
Journal:  Indian J Clin Biochem       Date:  2020-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.